Cargando…
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma
SIMPLE SUMMARY: Multiple drug resistant cancers develop all too soon in patients who received successful cancer treatment. A lack of treatment options often leaves palliative care as the last resort. We tested whether the insulin sensitizer, metformin, known to have anti-cancer activity, could impac...
Autores principales: | Arnason, Terra G., MacDonald-Dickinson, Valerie, Gaunt, Matthew Casey, Davies, Gerald F., Lobanova, Liubov, Trost, Brett, Gillespie, Zoe E., Waldner, Matthew, Baldwin, Paige, Borrowman, Devon, Marwood, Hailey, Vizeacoumar, Frederick S., Vizeacoumar, Franco J., Eskiw, Christopher H., Kusalik, Anthony, Harkness, Troy A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454423/ https://www.ncbi.nlm.nih.gov/pubmed/36077749 http://dx.doi.org/10.3390/cancers14174215 |
Ejemplares similares
-
Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1α
por: Arnason, Terra, et al.
Publicado: (2015) -
Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
por: Davies, Gerald, et al.
Publicado: (2017) -
The ubiquitin-conjugating enzyme, Ubc1, indirectly regulates SNF1
kinase activity via Forkhead-dependent transcription
por: Jiao, Rubin, et al.
Publicado: (2016) -
Mitotic degradation of yeast Fkh1 by the Anaphase Promoting Complex is required for normal longevity, genomic stability and stress resistance
por: Malo, Mackenzie E., et al.
Publicado: (2016) -
The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression
por: VanGenderen, Cordell, et al.
Publicado: (2020)